Tabs
FDA Center:
CDER
Time Period:
January 1, 2007 to May 31, 2013
Study Type:
Modular Program
Assessment Type:
Exploratory Analyses
Population / Cohort:
Patients with testosterone-related indications
Data Sources:
Mini-Sentinel Distributed Database (MSDD)